Back to Trades
Bunnage Mark E.
EVPChief Scientific OfficerCIK 0002100735
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
Bunnage Mark E., EVP, Chief Scientific Officer, has filed 4 reports across 1 company, totaling $2.1M in disclosed volume. Sales ($1.2M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| May 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $15.0K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $301.5K |
| Feb 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $930.5K |
| Feb 3 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Other | $0 |
4 filings